11.7 T 动态对比增强 MRI 评估姜黄素对胰腺纤维化的抗纤维化疗效——实验研究
研究在大鼠慢性胰腺炎模型中,用 11.7 T DCE-MRI 定量参数 Ktrans、Ve、Vp 评估胰腺纤维化及姜黄素抗纤维化效果。53 只大鼠完成 MR 检查,DBTC 4 周组 Ktrans 和 Vp 显著低于对照及 DBTC 2 周组,Ktrans、Vp 与纤维化含量及 α-SMA 表达呈负相关;姜黄素治疗 4 周组 Ktrans、Vp 显著高于 DBTC 4 周组。
核心结论
- DCE-MRI 参数 Ktrans 和 Vp 有潜力无创评估胰腺纤维化及姜黄素的抗纤维化治疗反应。
研究设计与样本
- 实验研究,70 只大鼠随机分为五组(对照组 n=10、DBTC 2 周组 n=15、DBTC 4 周组 n=15、DBTC+姜黄素 2 周组 n=15、DBTC+姜黄素 4 周组 n=15),用二丁基二氯化锡诱导胰腺纤维化,在 11.7 T MR 扫描仪上行 DCE-MRI,采用扩展 Tofts 模型导出 Ktrans、Ve、Vp 参数,以组织学纤维化含量和 α-SMA 表达为参照。
诊断标准与关键数值
- DBTC 注射后 4 周大鼠 Ktrans 为 0.30 ± 0.06 min,显著低于 DBTC 2 周大鼠的 0.49 ± 0.09 和对照大鼠的 0.62 ± 0.09;DBTC 4 周大鼠 Vp 为 0.048 ± 0.010 min-1,显著低于对照大鼠的 0.065 ± 0.011 min-1。Ktrans 与胰腺纤维化含量相关(r = -0.619,P < 0.001),Vp 与纤维化含量相关(r = -0.450,P < 0.001);Ktrans 与 α-SMA 表达相关(r = -0.688,P < 0.01),Vp 与 α-SMA 表达相关(r = -0.402,P < 0.01)。每日姜黄素治疗 4 周大鼠 Ktrans 为 0.51 ± 0.09,显著高于 DBTC 4 周大鼠的 0.30 ± 0.06;Vp 为 0.064 ± 0.015,显著高于 DBTC 4 周大鼠的 0.048 ± 0.010。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Pancreatic fibrosis is the hallmark of chronic pancreatitis (CP), which is associated with microcirculatory disturbance. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assess the perfusion and permeability of the pancreas by providing information about microcirculation. We hypothesize that DCE-MRI parameters can be utilized to assess pancreatic fibrosis and may furthermore provide an opportunity to evaluate response to antifibrotic treatment with curcumin. Our study was to evaluate the feasibility of quantitative DCE-MRI in assessing pancreatic fibrosis and the antifibrotic effect of curcumin in a rat model of CP.
MATERIALS AND METHODS: Pancreatic fibrosis was induced by injecting dibutyltin dichloride (DBTC). Seventy rats were randomized to five groups: the control group (n = 10); DBTC for 2 weeks (n = 15); DBTC for 4 weeks (n = 15); DBTC + curcumin for 2 weeks (n = 15); DBTC + curcumin for 4 weeks (n = 15). DCE-MRI was performed at an 11.7 T MR scanner. DCE-MRI quantitative parameters (Ktrans, Ve, and Vp) were derived from an extended Tofts model. Fibrosis content and DCE-MRI parameters were compared among the above groups (one-way analysis of variance). The correlations between DCE-MRI parameters and pancreatic fibrosis content as well as the expression of α-SMA were computed by Spearman correlation coefficients.
RESULTS: Fifty-three rats survived and underwent MR imaging. Ktrans in rats 4 weeks after DBTC injection was significantly lower than DBTC 2 weeks rats and control rats (0.30 ± 0.06 min vs 0.49 ± 0.09 vs 0.62 ± 0.09, respectively). Vp in DBTC 4 weeks rats was also significantly lower than control rats (0.048 ± 0.010 min-1 vs 0.065 ± 0.011 min-1, respectively). Ktrans and Vp significantly correlated with fibrosis content of pancreas (r = -0.619 and -0.450, all P < 0.001), and the expression of α-SMA (r = -0.688 and -0.402, all P < 0.01). Ktrans and Vp in rats with daily curcumin treatment for 4 weeks were significantly higher than DBTC 4 weeks rats (Ktrans, 0.51 ± 0.09 vs 0.30 ± 0.06; Vp, 0.064 ± 0.015 vs 0.048 ± 0.010).
CONCLUSION: DCE-MRI parameters (Ktrans and Vp) have the potential to noninvasively assess pancreatic fibrosis and the antifibrotic treatment response of curcumin.
引用
- Lu Y, Zhang T, Yang S, et al. Dynamic Contrast-Enhanced MRI Assessing Antifibrotic Therapeutic Effects of Pancreatic Fibrosis with Curcumin - An Experimental Study at 11.7 T. Acad Radiol. 2023. PMID: 37453883. doi:10.1016/j.acra.2023.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。